col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


39 Results       Page 1

 [1] 
Wiley: Immunology
  original article Date Title Authors   All Authors
1 [GO] 2025―May―05 Human Alveolar Macrophages Detect SARS-CoV-2 Envelope Protein Through TLR2 and TLR4 and Secrete Cytokines in Response Conor Grant, Emily Duffin, Finbarr O’Connell, Parthiban Nadarajan, Colm Bergin, Joseph Keane, Mary P. O'Sullivan
2 [GO] 2025―Apr―17 Clinical C3 Inhibition With AMY-101 Reveals Novel Insights Into IL-8-Driven Inflammation in COVID-19 Christina Antoniadou, Anastasia-Maria Natsi, Dimitrios C. Mastellos, Evangelos Papadimitriou, Efstratios Gavriilidis, Victoria Tsironidou, et al. (+10)
3 [GO] 2025―Feb―12 Impact of Pre-Infection COVID-19 Vaccination on the Incidence and Severity of Long COVID: A Retrospective Case-Control Study Elena Barado, Silvia Carlos, Laura Moreno-Galarraga, Fares Amer, Nicolás Escrivá, María Gabriela Torres, et al. (+2)
4 [GO] 2024―Mar―11 Omicron breakthrough infections after triple-dose inactivated COVID-19 vaccination: A comprehensive analysis of antibody and T-cell responses Tiandan Xiang, Xufeng Quan, Hang Jia, Hua Wang, Boyun Liang, Sumeng Li, et al. (+10)
5 [GO] 2023―Oct―12 Correction to “Eleven-month longitudinal study of antibodies in SARS-CoV-2 exposed and naïve primary health care workers upon COVID-19 vaccination”
6 [GO] 2023―Sep―08 Celiprolol and sympatho-immune interface in COVID-19 Hayder M. Al-Kuraishy, Ali K. Albuhadily, Ali I. Al-Gareeb, Maisra M. El-Bouseary, Athanasios Alexiou, Marios Papadakis, Gaber El-Saber Batiha
7 [GO] 2023―Aug―22 A robust platform for integrative spatial multi-omics analysis to map immune responses to SARS-CoV-2 infection in lung tissues Xiao Tan, Laura F. Grice, Minh Tran, Onkar Mulay, James Monkman, Tony Blick, et al. (+22)
8 [GO] 2023―May―27 Activation of Inflammasome complex in nasopharyngeal epithelial cells from patients with Coronavirus disease 2019 contributes to inflammatory state and worse disease outcomes Zahra Bagheri-Hosseinabadi, Mohsen Dehghan-Banadaki, Gholamhossein Taghipour Khaje Sharifi, Mitra Abbasifard
9 [GO] 2023―May―18 Ability of SpikoGen ®, an Advax-CpG adjuvanted recombinant spike protein vaccine, to induce cross-neutralising antibodies against SARS-CoV -2 variants Yoshikazu Honda-Okubo, Anna Antipov, Greiciely Andre, Saghar Barati, Hamidreza Kafi, Nikolai Petrovsky
10 [GO] 2023―Mar―01 T cell maturation is significantly affected by SARS-CoV -2 infection Laura Otto Walter, Chandra Chiappin Cardoso, Íris Mattos Santos-Pirath, Heloisa Zorzi Costa, Rafaela Gartner, Isabel Werle, et al. (+11)
11 [GO] 2022―Dec―26 The Role of HMGB1 in COVID-19-Induced Cytokine Storm and Its Potential Therapeutic Targets: A Review Sri Wulandari, Tri Wibawa
12 [GO] 2022―Sep―30 Alternative pathway dysregulation in tissues drives sustained complement activation and predicts outcome across the disease course in COVID-19 Matthew K. Siggins, Kate Davies, Rosie Fellows, Ryan S. Thwaites, J. Kenneth Baillie, Malcolm G. Semple, et al. (+355)
13 [GO] 2022―Sep―15 Transcriptomic profiling of cardiac tissues from SARS-CoV -2 patients identifies DNA damage Arutha Kulasinghe, Ning Liu, Chin Wee Tan, James Monkman, Jane E. Sinclair, Dharmesh D. Bhuva, et al. (+22)
14 [GO] 2022―Aug―16 The immune response as a double-edged sword: the lesson learnt during the COVID -19 pandemic Chiara Agrati, Rita Carsetti, Veronica Bordoni, Alessandra Sacchi, Concetta Quintarelli, Franco Locatelli, et al. (+2)
15 [GO] 2022―Jul―31 Eleven-month longitudinal study of antibodies in SARS-CoV -2 exposed and naïve primary health care workers upon COVID -19 vaccination Carlota Dobaño, Anna Ramírez-Morros, Selena Alonso, Gemma Ruiz-Olalla, Rocío Rubio, Marta Vidal, et al. (+13)
16 [GO] 2022―Jun―27 Immunogenicity and Safety of SpikoGen ®, an Adjuvanted Recombinant SARS-CoV -2 Spike Protein vaccine as a Homologous and Heterologous Booster Vaccination: A Randomized Placebo-Controlled Trial Payam Tabarsi, Nassim Anjidani, Ramin Shahpari, Khashayar Roshanzamir, Newsha Fallah, Greiciely Andre, et al. (+2)
17 [GO] 2022―Jun―25 Comparison of the Immunogenicity of five COVID-19 vaccines in Sri Lanka Chandima Jeewandara, Inoka Sepali Aberathna, Saubhagya Danasekara, Laksiri Gomes, Suranga Fernando, Dinuka Guruge, et al. (+19)
18 [GO] 2022―Jun―25 The kinetics of IgG subclasses and contributions to neutralizing activity against SARS-CoV-2 wild-type strain and variants in healthy adults immunized with inactivated vaccine Weixin Chen, Lichi Zhang, Juan Li, Shuang Bai, Yali Wang, Bing Zhang, et al. (+4)
19 [GO] 2022―May―16 Antibodies to SARS-CoV-2 in patients with primary immunodeficiencies treated with nonspecific immunoglobulins Jorge Eguía, Mª Araceli Caballero-Rabasco, Mª Lourdes Cos, Santiago Grau, Leonardo Mellibovsky, Eduardo Villegas, et al. (+5)
20 [GO] 2022―Apr―18 Editorial: Diverse responses to SARS-CoV -2 in the human population Greg M. Delgoffe
21 [GO] 2022―Apr―09 The effect of age on the magnitude and longevity of Th1-directed CD4 T cell responses to SARS-CoV -2 Ryan G. Nattrass, Lisa Krafft, Polina Zjablovskaja, Marc Schuster, Bahram Kasmapour, Cem Sarisoy, et al. (+3)
22 [GO] 2022―Feb―14 HLA-DR polymorphism in SARS-CoV-2 infection and susceptibility to symptomatic COVID-19 Stuart Astbury, Catherine J Reynolds, David K Butler, Diana C Munoz-Sandoval, Kai-Min Lin, Franziska P Pieper, et al. (+24)
23 [GO] 2022―Feb―11 The Relationship between Peripheral Immune Response and Disease Severity in SARS-CoV-2-infected Subjects: A Cross-sectional Study Laura Otto Walter, Chandra Chiappin Cardoso, Íris Mattos Santos-Pirath, Heloisa Zorzi Costa, Rafaela Gartner, Isabel Werle, et al. (+10)
24 [GO] 2022―Feb―10 HLA-dependent variation in SARS-CoV-2 CD8+ T cell cross-reactivity with human coronaviruses Paul R. Buckley, Chloe H. Lee, Mariana Pereira Pinho, Rosana Ottakandathil Babu, Jeongmin Woo, Agne Antanaviciute, et al. (+3)
25 [GO] 2022―Jan―12 COVID-19 vaccination and treatment in vulnerable populations Greg M. Delgoffe
26 [GO] 2021―Dec―27 New-onset autoimmune phenomena post COVID-19 vaccination Yue Chen, Zhiwei Xu, Peng Wang, Xiao-Mei Li, Zong-Wen Shuai, Dong-Qing Ye, Hai-Feng Pan
27 [GO] 2021―Nov―14 Identifying SARS-CoV-2 “memory” NK cells from COVID-19 convalescent donors for adoptive cell therapy Lara Herrera, Myriam Martin-Inaraja, Silvia Santos, Marta Inglés-Ferrándiz, Aida Azkarate, Miguel A. Perez-Vaquero, et al. (+9)
28 [GO] 2021―Nov―14 Whole blood-based measurement of SARS-CoV-2-specific T cells reveals asymptomatic infection and vaccine immunogenicity in healthy subjects and patients with solid organ cancers Martin J. Scurr, Wioleta M. Zelek, George Lippiatt, Michelle Somerville, Stephanie E. A. Burnell, Lorenzo Capitani, et al. (+15)
29 [GO] 2021―Aug―12 Sensitive detection of anti-spike antibodies enables improved understanding of SARS-CoV-2 pathogenesis Simon Milling
30 [GO] 2021―Jun―11 Diabetes and susceptibility to infections: implication for COVID-19 Gustav van Niekerk, Michelle van der Merwe, Anna-Mart Engelbrecht
31 [GO] 2021―May―18 Reimagining lab-based immunology education in the time of COVID-19 Thomas S. Wilkinson, Rob Nibbs, Nigel J. Francis
32 [GO] 2021―May―01 Development of a high sensitivity ELISA detecting IgG, A & M antibodies to the SARS-CoV-2 spike glycoprotein in serum and saliva Sian E. Faustini, Sian E. Jossi, Marisol Perez-Toledo, Adrian M. Shields, Joel D. Allen, Yasunori Watanabe, et al. (+22)
33 [GO] 2021―Mar―20 Emerging roles of extracellular vesicles in COVID-19, a double-edged sword? Xiaohuan Xia, Ping Yuan, Yihan Liu, Yi Wang, Weijun Cao, Jialin C. Zheng
34 [GO] 2020―Sep―22 T cell responses and therapies against SARS-CoV-2 infection Salman M. Toor, Reem Saleh, Varun Sasidharan Nair, Rowaida Z Taha, Eyad Elkord
35 [GO] 2020―Sep―01 Quantitative and qualitative alterations of circulating myeloid cells and plasmacytoid DC in SARS-CoV-2 infection Benedetta Peruzzi, Sara Bencini, Manuela Capone, Alessio Mazzoni, Laura Maggi, Lorenzo Salvati, et al. (+13)
36 [GO] 2020―Jul―20 Viruses and asthma: the role of common respiratory viruses in asthma and its potential meaning for SARS-CoV-2 Natalija Novak, Beatriz Cabanillas
37 [GO] 2020―Jul―08 Elevated interleukin-6, interleukin-10 and neutrophil : lymphocyte ratio as identifiers of severe coronavirus disease 2019 Andrew Godkin, Ian R. Humphreys
38 [GO] 2020―May―27 The early landscape of COVID-19 vaccine development in the UK and rest of the world Hannah R Sharpe, Ciaran Gilbride, Elizabeth Allen, Sandra Belij-Rammerstorfer, Cameron Bissett, Katie Ewer, Teresa Lambe
39 [GO] 2020―May―27 Immunopathological characteristics of coronavirus disease 2019 cases in Guangzhou, China Mingkai Tan, Yanxia Liu, Ruiping Zhou, Xilong Deng, Fang Li, Kaiyan Liang, Yaling Shi
 [1] 

39 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.005 sec